What conditions is tranylcypromine approved to treat?
Tranylcypromine (a monoamine oxidase inhibitor, MAOI) is indicated for depressive illness. Specific approved indications can vary by country and product labeling.
What depression-related uses does tranylcypromine have in practice?
Tranylcypromine is generally used for major depressive disorder, especially when other antidepressants have not worked or when a clinician is using it for treatment-resistant depression. As with other MAOIs, its use typically depends on the patient’s ability to follow dietary and medication restrictions due to the risk of serious interactions.
What else might people mean when they search “tranylcypromine indications”?
Some searches conflate MAOI indications with older or off-label uses (for example, other mood disorders). Whether those uses apply to a given patient depends on local regulatory approval and the prescriber’s judgment.
What patient safety issues affect tranylcypromine use for its indications?
Because tranylcypromine is an MAOI, patients must avoid certain food types (high in tyramine) and many drug combinations that can trigger dangerous reactions, which can limit its use even when the indication is depression.
Looking up exact wording: where to find the official indication language
For the most accurate, up-to-date indication wording, check the specific country’s prescribing information or drug label for the exact tranylcypromine product you’re using.
Sources: None provided.